{
  "schema_version": "1.3.1",
  "doc": {
    "doc_id": "b2d23fdee07228737adc7b5759b4d93d",
    "title": "Jefferies",
    "source_uri": "2025-08-31/1H25 Miss Guidance Cut Further1H25 Miss Guidance Cut Further_2025-08-31",
    "language": "en",
    "timestamps": {
      "ingested_at": "2025-10-27T00:37:52.757759",
      "extracted_at": "2025-10-27T00:37:52.757768"
    },
    "extraction_run": {
      "vision_model": "deepseek-ai/DeepSeek-OCR",
      "synthesis_model": "rule-based-engine",
      "pipeline_steps": [
        "ocr",
        "rule_extraction",
        "figure_vision"
      ],
      "processing_metadata": {
        "pages_processed": 9,
        "successful_pages": 9,
        "date": "2025-08-31",
        "publication": "2025-08-31",
        "authors": [],
        "markdown_cleaning": {
          "removed_sections": 2,
          "removed_paragraphs": 9,
          "reduction_ratio": 0.30686556341128635
        },
        "input_relative_path": "2025-08-31"
      }
    }
  },
  "passages": [
    {
      "passage_id": "fc9dea0105a3b5e9",
      "text": "China (PRC) | Healthcare Services Gushengtang",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "1b90c66afa99ed40",
      "text": "GST reported \\(10\\%\\) yoy revenue growth in 1H25, and cut FY25 rev guidance further, to \\(10 - 15\\%\\) . We think the \\(20\\%\\) FY26 rev guidance is likely to miss on: 1) slowdown of mature stores; 2) B/S constraints pose challenges in supporting sizable M&A at favorable valuations; 3) intensifying competition from long- standing TCM leaders, such as Tong Ren Tang. Meanwhile, VBP on decoctions could pressure profitability further. Maintain UNPF.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "f13edec2d4a20900",
      "text": "1H25 miss, guidance cut further - GST's organic revenue growth slowed to \\(8\\%\\) in 1H25, (vs \\(28\\%\\) in 2024). Mgmt has further reduced FY25 revenue guidance to \\(10 - 15\\%\\) yoy (lowered to \\(+25\\%\\) from \\(+30\\%\\) in April) while maintaining a \\(\\sim 30\\%\\) yoy profit target for FY25. Although mgmt guided \\(\\sim 20\\%\\) revenue growth in FY26 on external expansion through sizable M&As, we think it is likely to miss again on: 1) growth slowdown of mature stores; 2) balance sheet constraints ( \\(\\sim\\) RMB1bn cash on hand) pose challenges in supporting sizable M&As at favorable valuations; 3) intensifying competition from long- standing TCM leaders such as Tong Ren Tang Clinics.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "4d5533786a4402f2",
      "text": "We don't believe Al+TCM is the solution for GST - Given the nature of TCM treatment, we believe patients visit TCM clinics primarily for the expertise of TCM masters, who are scarce. Though GST has explored online consultations and Al + TCM tools to simulate the masters' experience and serve more clients, we believe this approach is unconvincing to patients, as the essence of TCM lies in bespoke treatments based on in- person consultations.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "bf4c2203dc4b903f",
      "text": "VBP on decoctions to pressure profitability - TCM decoction GPO has become one of the NHSA's priorities in 2025. Seventy percent of GST's profit is from regular decoctions; VBP would dilute its centralized supply- chain edge and pressure profitability. GST has been improving product mix with more TCM paste and in- hospital preparations to ease margin pressure, but transitioning to these alternatives will take time as GST needs to streamline the manufacturing supply chain or explore partnerships to scale up in- house preparations.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "60cbdd34b21b6cdd",
      "text": "1H25 Results Recap - 1H25 revenue of Rmb1.5bn \\((+10\\%\\) yoy), driven by a \\(15\\%\\) yoy growth in customer volume, offset by a \\(5\\%\\) yoy decline in the ASP. Mgmt remains confident in overseas expansion, with SG sales increased to Rmb2mn in 1H25 from Rmb1mn in 1H24. GPM increased to \\(30.6\\%\\) in 1H25 from \\(29.4\\%\\) in 1H24, benefiting from a \\(7\\%\\) yoy reduction in rent cost (adding \\(1\\%\\) to GPM, on our estimates) and operating expense savings. SG&A ratio declined to \\(18.2\\%\\) in 1H25 vs \\(19.8\\%\\) in 1H24. Net profit grew to Rmb152mn \\((+42\\%\\) yoy), or \\(+15\\%\\) if excluding one- offs.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "3f6088831f7432cf",
      "text": "Implications - We revise revenue lower to factor in lower- than- expected organic growth, and adjust net profit from the cost saving in SG&A. Maintain UNPF, with PT unchanged at HK\\$26.0.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "d325681538a97e35",
      "text": "FY (Dec)2024A2025E2026E2027ERev. (MM)3,022.43,445.53,962.34,437.8EBITDA (MM)506.9592.2610.0661.0Net Profit306.8352.2377.6407.8EPS1.221.431.541.66",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "93580a7aafb533bc",
      "text": "Please see analyst certifications, important disclosure information, and information regarding the status of non-US analysts on pages 4-9 of this report. \\\\* Jefferies Hong Kong Limited",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "8cb77674da75123e",
      "text": "RATINGUNDERPERFORMPRICEHK$32.50*PRICE TARGET | % TO PTHK$26.00 | -20%52W HIGH-LOWHK$48.95 - HK$25.50FLOAT (%) | ADV MM (USD)60.1% | 58.82MARKET CAPHK$8.0B | HK$8.0BTICKER2273 HK*Prior trading day’s closing price unless otherwise noted.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "af36c3de0e7a01bb",
      "text": "FY (Dec)CHANGE TO JEFEJEF vs CONS20252026REV-7%-9%EPS+14%+20%2025 (RMB)1Half2HalfEPS--PREV1.26",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "73b3c5cea85bfdc9",
      "text": "We rate at Gushengtang UNPF given: 1) uncertainty about expansion into lower- tier cities with weaker out- of- pocket purchasing power and local clinic competition; 2) margin pressure from GPO on TCM decoctions, disrupting GST's core advantage in supply chain mgmt, with \\(70\\%\\) of profit potentially affected; 3) stricter reimbursement policy on TCM clinics due to budgeting pressure.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "f6c6d3e3fa19cf3d",
      "text": "Risk/Reward - 12 Month View",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "cfff82bb9f4addb9",
      "text": "Steady growth in market size of TCM healthcare services.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "0a96918da6a8da20",
      "text": "Steady clinic network expansion.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "b9f8203a944c7bd3",
      "text": "Stricter reimbursement policy on TCM clinics due to budgeting pressure.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "8d1c85a59cbcf749",
      "text": "PT of HK\\$26 based on DCF valuation.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "4860cfb98c72268f",
      "text": "Stronger- than- expected growth in TCM healthcare services market size. Faster- than- expected clinic network expansion. Faster- than- expected market share gain. Faster- than- expected margin expansion. Upside PT of HK\\$39 based on DCF valuation.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "e106fe3fed1bc666",
      "text": "Weaker- than- expected market size growth for TCM healthcare services. Slower- than- expected clinic network expansion. Shrinking market share due to competition. Worse- than- expected margin pressure. Downside PT of HK\\$18 based on DCF valuation.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "d95194216237a58a",
      "text": "Top Material Issues: 1) Social responsibility, 2) Protecting the rights of shareholders, 3) Protecting the rights of clients, 4) Protecting the rights of suppliers, 5) Protecting the rights of employees, 6) Public relations, 7) Ensuring product quality and safety, 8) Environmental protection and sustainable development, 9) Adhering to business ethics.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "481ab91584b18e2b",
      "text": "1) Greenhouse gas emphasized: achieve annual carbon emission growth not exceeding \\(5\\%\\) in the context of expected growth of \\(10\\%\\) in the production plan in 2023",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "33a43ca057d1290f",
      "text": "2) Exhaust gas: continuously reduce exhaust gas emissions.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "b268428f2622292c",
      "text": "3) Solid waste: generate no more than 8kg of hazardous and non-hazardous solid waste per month in each clinic",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "a9eba16fbc21572e",
      "text": "4) Energy management: reduce energy consumption per unit income on a continuous basis",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "a553e831de1f966c",
      "text": "5) Water resources: improve the utilization efficiency of water resources and reduce the water resource consumption per unit income year by year",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "2b8de23711ad2f7f",
      "text": "1) What are the projected investments and potential savings in achieving the established ESG targets? \n2) What is the strategy for talent retention and development to improve human capital?",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "a87fc542fb575392",
      "text": "- Slower revenue growth and lower revenue per store - 2025- Lower profit margin amid policy headwinds and slower earnings growth - 2025- Stricter reimbursement policy on TCM clinics - 2025- Expanded scope and larger-than-expected price cuts from further rounds of TCM decoction GPOs - 2025",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "4b194b454f6a5670",
      "text": "Gushengtang is a top- ten private TCM healthcare service provider in China (with \\(0.6\\%\\) market share in 2020), and the third- largest TCM services chain in China in terms of number of institutions (i.e. number of hospitals and clinics) per company estimates. It is the first and only TCM service provider listed on the Hong Kong and China stock markets.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "dccc69dc21f1cbc3",
      "text": "Our HK\\$26.0 price target for Gushengtang is derived from DCF methodology, which factors in our revenue and earnings forecasts up to 2034E, with WACC of \\(10.6\\%\\) and terminal growth rate of \\(2.0\\%\\) . Risks: 1) regulatory risks in TCM services, 2) competition, 3) talent retention risk, 4) uncertainty on partnerships, 5) hospital network expansion risk, 6) medical disputes and legal issues.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "de5b542fa7c7f00b",
      "text": "(Article 3(1)e and Article 7 of MAR)",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "a68ae2b119e57220",
      "text": "Recommendation Published Recommendation Distributed",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "9bb9dc13ebfc6bc0",
      "text": "August 31, 2025 12:02 P.M. August 31, 2025 12:02 P.M.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "95e575965a0ec87f",
      "text": "Buy - Describes securities that we expect to provide a total return (price appreciation plus yield) of \\(15\\%\\) or more within a 12- month period. Hold - Describes securities that we expect to provide a total return (price appreciation plus yield) of plus \\(15\\%\\) or minus \\(10\\%\\) within a 12- month period. Underperform - Describes securities that we expect to provide a total return (price appreciation plus yield) of minus \\(10\\%\\) or less within a 12- month period. The expected total return (price appreciation plus yield) for Buy rated securities with an average security price consistently below \\(10\\) is \\(20\\%\\) or more within a 12- month period as these companies are typically more volatile than the overall stock market. For Hold rated securities with an average security price consistently below \\(10\\) , the expected total return (price appreciation plus yield) is plus or minus \\(20\\%\\) within a 12- month period. For Underperform rated",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "7e4990ea60981e8a",
      "text": "securities with an average security price consistently below \\(10, the expected total return (price appreciation plus yield) is minus 20% or less within a 12- month period.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "998d686d45d67f7d",
      "text": "NR - The investment rating and price target have been temporarily suspended. Such suspensions are in compliance with applicable regulations and/or Jefferies policies.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "c721c59fbbec7059",
      "text": "CS - Coverage Suspended. Jefferies has suspended coverage of this company.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "9291c62e4474d69a",
      "text": "NC - Not covered. Jefferies does not cover this company.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "ef3df05c9c9bcc33",
      "text": "Restricted - Describes issuers where, in conjunction with Jefferies engagement in certain transactions, company policy or applicable securities regulations prohibit certain types of communications, including investment recommendations.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "d3913bf9bc576e06",
      "text": "Monitor - Describes securities whose company fundamentals and financials are being monitored, and for which no financial projections or opinions on the investment merits of the company are provided.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "9971627722800e1b",
      "text": "Jefferies methodology for assigning ratings may include the following: market capitalization, maturity, growth/value, volatility and expected total return over the next 12 months. The price targets are based on several methodologies, which may include, but are not restricted to, analyses of market risk, growth rate, revenue stream, discounted cash flow (DCF), EBITDA, EPS, cash flow (CF), free cash flow (FCF), EV/EBITDA, P/E, PE/growth, P/CF, P/FCF, premium (discount)/average group EV/EBITDA, premium (discount)/average group P/E, sum of the parts, net asset value, dividend returns, and return on equity (ROE) over the next 12 months.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "b7f334da95cb1d4e",
      "text": "Jefferies Franchise PicksJefferies Franchise Picks include stock selections from among the best stock ideas from our equity analysts over a 12 month period. Stock selection is based on fundamental analysis and may take into account other factors such as analyst conviction, differentiated analysis, a favorable risk/reward ratio and investment themes that Jefferies analysts are recommending. Jefferies Franchise Picks will include only Buy rated stocks and the number can vary depending on analyst recommendations for inclusion. Stocks will be added as new opportunities arise and removed when the reason for inclusion changes, the stock has met its desired return, if it is no longer rated Buy and/or if it triggers a stop loss. Stocks having 120 day volatility in the bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intended to represent a recommended portfolio of stocks and is not sector based, but we may note where we believe a Pick falls within an investment style such as growth or value.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "6b891ed40200e527",
      "text": "Gushengtang Holdings Ltd (2273 HK: HK\\$32.50, UNDERPERFORM)",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "033a3fd2ea7b2844",
      "text": "Rating and Price Target History for: Tong Ren Tang (600085 CH) as of 04-13-2023",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "6f17139f8ba55299",
      "text": "Notes: Each box in the Rating and Price Target History chart above represents actions over the past three years in which an analyst initiated on a company, made a change to a rating or price target of a company or discontinued coverage of a company. Legend:",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "dc905642821902b2",
      "text": "I: Initiating Coverage \nD: Dropped Coverage \nB: Buy \nH: Hold \nUP: Underperform",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "522bc7f01fc00716",
      "text": "Distribution of Ratings",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "0ee2f3d7f759dbb7",
      "text": "CountPercentCountPercentCountPercentBUY210760.60%37017.56%1185.60%HOLD121234.86%1078.83%221.82%UNDERPERFORM1584.54%31.90%31.90%",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "9e393d99e1aeda3b",
      "text": "Jefries does busines and seeks to do business with companies covered in its research reports, and expects to receive or intends to seek compensation for investment banking services among other activities from such companies. As a result, investors should be aware that Jefferies may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Jefferies Equity Research refers to research reports produced by analysts employed by one of the following Jefferies Financial Group Inc. (Jefferies) companies:",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "e921ebe37be2728e",
      "text": "United States: Jefferies LLC which is an SEC registered broker- dealer and a member of FINRA (and distributed by Jefferies Research Services, LLC, an SEC registered Investment Adviser, to clients paying separately for such research).",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "cbca081d97debfb1",
      "text": "Canada: Jefferies Securities Inc., which is an investment dealer registered in each of the thirteen Canadian jurisdictions and a dealer member of the Canadian Investment Regulatory Organization, including research reports produced jointly by Jefferies Securities Inc. and another Jefferies entity (and distributed by Jefferies Securities Inc.).",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "5fda41e5b2f73933",
      "text": "Where Jefferies Securities Inc. distributes research reports produced by Jefferies LLC, Jefferies International Limited, Jefferies (Japan) Limited, Tokyo Branch or Jefferies India Private Limited, you are advised that each of Jefferies LLC, Jefferies International Limited, Jefferies (Japan) Limited, Tokyo Branch and Jefferies India Private Limited operates as a dealer in your jurisdiction under an exemption from the dealer registration requirements contained in National Instrument 31- 103 Registration Requirements, Exemptions and Ongoing Registrant Obligations and, as such, each of Jefferies LLC, Jefferies International Limited, Jefferies (Japan) Limited, Tokyo Branch and Jefferies India Private Limited is not required to be and is not a registered dealer or adviser in your jurisdiction. You are advised that where Jefferies LLC or Jefferies International Limited prepared this research report, it was not prepared in accordance with Canadian disclosure requirements relating to research reports in Canada.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "3fe39309fb957cab",
      "text": "United Kingdom: Jefferies International Limited, which is authorized and regulated by the Financial Conduct Authority, registered in England and Wales No. 1978621; registered office: 100 Bishopsgate, London EC2N 4JL; telephone +44 (0)20 7029 8000; facsimile +44 (0)20 7029 8010.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "b4a3ae84c10509f8",
      "text": "Japan: Jefferies (Japan) Limited, Tokyo Branch, which is a securities company registered by the Financial Services Agency of Japan and is a member of the Japan Securities Dealers Association; located at Tokyo Midtown Hibiya 30F Hibiya Mitsui Tower, 1- 1- 2 Yurakucho, Chiyoda- ku, Tokyo 100- 0006; telephone +813 5251 6100; facsimile +813 5251 6101.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "839c3aca1e3dc1e6",
      "text": "Australia: Jefferies (Australia) Pty Limited (ACN 623 059 898), which holds an Australian financial services license (AFSL 504712) and is located at Level 20, 60 Martin Place, Sydney NSW 2000; telephone +61 2 9364 2800.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "1124a431053d9548",
      "text": "Dubai: Jefferies International Limited, Dubai branch, which is licensed by the Dubai Financial Services Authority (DFSA Reference Number F007325); registered office Unit L31- 06, L31- 07, Level 31, ICD Brookfield Pace, DIFC, PO Box 121208, Dubai, UAE.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "321dd51deb5bbd56",
      "text": "This report was prepared by personnel who are associated with Jefferies (Jefferies Securities Inc., Jefferies International Limited, Jefferies GmbH, Jefferies Hong Kong Limited, Jefferies Singapore Limited, Jefferies (Japan) Limited, Tokyo Branch, Jefferies India Private Limited), and Jefferies (Australia) Pty Ltd; or by personnel who are associated with both Jefferies LLC and Jefferies Research Services LLC (\"JRS\"). Jefferies LLC is a US registered broker- dealer and is affiliated with JRS, which is a US registered investment adviser. JRS does not create tailored or personalized research and all research provided by JRS is impersonal. If you are paying separately for this research, it is being provided to you by JRS. Otherwise, it is being provided by Jefferies LLC. Jefferies LLC, JRS, and their affiliates are collectively referred to below as \"Jefferies\". Jefferies may seek to do business with companies covered in this research report. As a result, investors should be aware that Jefferies may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only one of many factors in making their investment decisions. Specific conflict of interest and other disclosures that are required by FINRA, the Canadian Investment Regulatory Organization and other rules are set forth in this disclosure section.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "107189319e3c7bb2",
      "text": "If you are receiving this report from a non- US Jefferies entity, please note the following: Unless prohibited by the provisions of Regulation S of the U.S. Securities Act of 1933, as amended, this material is distributed in the United States by Jefferies LLC, which accepts responsibility for its contents in accordance with the provisions of Rule 15a- 6 under the US Securities Exchange Act of 1934, as amended. Transactions by or on behalf of any US person may only be effected through Jefferies LLC. In the United Kingdom and European Economic Area this report is issued and/or approved for distribution by Jefferies International Limited (\"JIL\") and/or Jefferies GmbH and is intended for use only by persons who have, or have been assessed as having, suitable professional experience and expertise, or by persons to whom it can be otherwise lawfully distributed. Jefferies LLC, JIL, Jefferies GmbH and their affiliates, may make a market or provide liquidity in the financial instruments referred to in this report; and where they do make a market, such activity is disclosed specifically in this report under \"company specific disclosures\".",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "d6c3f97d3dcf667f",
      "text": "For Canadian investors, this material is intended for use only by professional or institutional investors. None of the investments or investment services mentioned or described herein is available to other persons or to anyone in Canada who is not a \"permitted client\" as defined by National Instrument 31- 103 Registration Requirements, Exemptions and Ongoing Registrant Obligations, as applicable. This research report is a general discussion of the merits and",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "6502e6c976152c1d",
      "text": "first considering whether any advice or recommendation in this report is suitable for the recipient based on the recipient's particular circumstances and, if appropriate or otherwise needed, seeking professional advice, including tax advice. Jefferies does not perform any suitability or other analysis to check whether an investment decision made by the recipient based on this report is consistent with a recipient's investment objectives, portfolio holdings, strategy, financial situation, or needs.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "d57f1b53836a36bb",
      "text": "By providing this report, neither JRS nor any other Jefferies entity accepts any authority, discretion, or control over the management of the recipient's assets. Any action taken by the recipient of this report, based on the information in the report, is at the recipient's sole judgment and risk. The recipient must perform his or her own independent review of any prospective investment. If the recipient uses the services of Jefferies LLC (or other affiliated broker- dealers), in connection with a purchase or sale of a security that is a subject of these materials, such broker- dealer may act as principal for its own accounts or as agent for another person. Only JRS is registered with the SEC as an investment adviser; and therefore neither Jefferies LLC nor any other Jefferies affiliate has any fiduciary duty in connection with distribution of these reports.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "2d79f37fd24f2b3c",
      "text": "The price and value of the investments referred to herein and the income from them may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Fluctuations in exchange rates could have adverse effects on the value or price of, or income derived from, certain investments.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "8c560c1dac16a3b0",
      "text": "This report may contain forward looking statements that may be affected by inaccurate assumptions or by known or unknown risks, uncertainties, and other important factors. As a result, the actual results, events, performance or achievements of the financial product may be materially different from those expressed or implied in such statements.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "b201f20d64a0ad2c",
      "text": "This report has been prepared independently of any issuer of securities mentioned herein and not as agent of any issuer of securities. No Equity Research personnel have authority whatsoever to make any representations or warranty on behalf of the issuer(s). Any comments or statements made herein are those of the Jefferies entity producing this report and may differ from the views of other Jefferies entities.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "5bb3c833273a3c6a",
      "text": "This report may contain information obtained from third parties, including ratings from credit ratings agencies such as Standard & Poor's, and information derived from third- party or proprietary generative artificial intelligence (Gen AI) models. Jefferies does not guarantee the accuracy, completeness, timeliness or availability of this information, and is not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, or for the results obtained from the use of such content. Neither Jefferies nor any third- party content providers, including providers of Gen AI models, give any express or implied warranties, including, but not limited to, any warranties of merchantability or fitness for a particular purpose or use. Neither Jefferies nor any third- party content provider shall be liable for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs,",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "c23caf4943fcce2f",
      "text": "expenses, legal fees, or losses (including lost income or profits and opportunity costs) in connection with any use of their content, including ratings. Credit ratings are statements of opinions and are not statements of fact or recommendations to purchase, hold or sell securities. They do not address the suitability of securities or the suitability of securities for investment purposes, and should not be relied on as investment advice. Reproduction and distribution of third party content in any form is prohibited except with the prior written permission of the related third party.",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "2d04cc6fd884e620",
      "text": "Jefferies research reports are disseminated and available electronically, and, in some cases, also in printed form. Electronic research is simultaneously made available to all clients. This report or any portion hereof may not be copied, reprinted, sold, or redistributed or disclosed by the recipient or any third party, by content scraping or extraction, automated processing, or any other form or means, without the prior written consent of Jefferies. Any unauthorized use is prohibited. Neither Jefferies nor any of its respective directors, officers or employees, is responsible for guaranteeing the financial success of any investment, or accepts any liability whatsoever for any direct, indirect or consequential damages or losses arising from any use of this report or its contents. Nothing herein shall be construed to waive any liability Jefferies has under applicable U.S. federal or state securities laws.",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "082095b815c595af",
      "text": "For Important Disclosure information relating to JRS, please see https://adviserinfo.sec.gov/lAPD/Content/Common/crd_iapd_Brochure.aspx? BRCHR_VRSN_ID=483878 and https://adviserinfo.sec.gov/Firm/292142 or visit our website at https://javatar.bluematrix.com/sellside/Disclosures.action, or www.jefferies.com, or call 1.888. JEFFERIES.",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "bb5c972f1b7d4469",
      "text": "\\(①\\) 2025 Jefferies",
      "page": 8,
      "section": null
    }
  ],
  "entities": [
    {
      "entity_id": "091ea27f0512d847",
      "name": "Base Case",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "7860a2554c61a53f",
      "name": "Canadian Investment",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "6e4788dbad025b7b",
      "name": "Company Description",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "ba87032713b76abb",
      "name": "Company Targets",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "8bb7d9a681cb9e40",
      "name": "Company Valuation",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "4b9be408e155a05b",
      "name": "Coverage Suspended",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "e9cd18ef1469e32c",
      "name": "DFSA Reference",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "6ba4b0a762d135f4",
      "name": "Dealers Association",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "ef7939250a8b4d95",
      "name": "Differ\n\nWe",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "e736f0c0f1f7561e",
      "name": "Disclosures\n\nJefries",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "8f604cf70e528f65",
      "name": "Downside PT",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "98c5e1b74a254ba0",
      "name": "Downside Scenario",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "a87247c304f6889b",
      "name": "Dropped Coverage",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "8ed3fafbb18d7293",
      "name": "Dubai Financial",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "21bc9aa97d2d9364",
      "name": "European Economic",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "88ae349d7f27936d",
      "name": "Exchange Act",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "c30d804de2e4ac53",
      "name": "Financial Conduct",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "f279b250fb9ccc9a",
      "name": "Financial Services",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "9acf1646d3aff849",
      "name": "For Canadian",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "f03268a54a73d4c7",
      "name": "For Hold",
      "type": "company",
      "aliases": []
    }
  ],
  "data": {
    "figures": [
      {
        "type": "line",
        "title": "Rating and Price Target History for: Tong Ren Tang (600085 CH) as of 04-13-2023",
        "page": 6,
        "axes": {
          "x": {
            "type": "time",
            "labels": [
              "Jul 20",
              "Oct 20",
              "Jan 21",
              "Apr 21",
              "Jul 21",
              "Oct 21",
              "Jan 22",
              "Apr 22",
              "Jul 22",
              "Oct 22",
              "Jan 23",
              "Apr 23"
            ]
          },
          "y": {
            "unit": "CNY",
            "range": {
              "min": 20,
              "max": 60
            }
          }
        },
        "series": [
          {
            "name": "Price",
            "unit": "CNY",
            "values": [
              22.0,
              20.5,
              22.0,
              28.0,
              43.0,
              35.0,
              38.0,
              48.0,
              40.0,
              48.0,
              42.0,
              55.0
            ]
          }
        ],
        "figure_id": "1cc098f815ad2743",
        "provenance": {
          "page": 6
        }
      },
      {
        "type": "line",
        "title": "Rating and Price Target History for: Gushengtang Holdings Ltd (2273 HK) as of 08-29-2025",
        "page": 5,
        "axes": {
          "x": {
            "type": "time",
            "labels": [
              "Oct 22",
              "Jan 23",
              "Apr 23",
              "Jul 23",
              "Oct 23",
              "Jan 24",
              "Apr 24",
              "Jul 24",
              "Oct 24",
              "Jan 25",
              "Apr 25",
              "Jul 25"
            ]
          },
          "y": {
            "unit": "HK$",
            "range": {
              "min": 25,
              "max": 65
            }
          }
        },
        "series": [
          {
            "name": "Price",
            "unit": "HK$",
            "values": [
              {
                "date": "2022-10",
                "value": 28
              },
              {
                "date": "2022-11",
                "value": 32
              },
              {
                "date": "2022-12",
                "value": 35
              },
              {
                "date": "2023-01",
                "value": 40
              },
              {
                "date": "2023-02",
                "value": 45
              },
              {
                "date": "2023-03",
                "value": 50
              },
              {
                "date": "2023-04",
                "value": 55
              },
              {
                "date": "2023-05",
                "value": 60
              },
              {
                "date": "2023-06",
                "value": 55
              },
              {
                "date": "2023-07",
                "value": 50
              },
              {
                "date": "2023-08",
                "value": 45
              },
              {
                "date": "2023-09",
                "value": 40
              },
              {
                "date": "2023-10",
                "value": 35
              },
              {
                "date": "2023-11",
                "value": 40
              },
              {
                "date": "2023-12",
                "value": 45
              },
              {
                "date": "2024-01",
                "value": 50
              },
              {
                "date": "2024-02",
                "value": 45
              },
              {
                "date": "2024-03",
                "value": 40
              },
              {
                "date": "2024-04",
                "value": 35
              },
              {
                "date": "2024-05",
                "value": 30
              },
              {
                "date": "2024-06",
                "value": 28
              },
              {
                "date": "2024-07",
                "value": 30
              },
              {
                "date": "2024-08",
                "value": 35
              },
              {
                "date": "2024-09",
                "value": 40
              },
              {
                "date": "2024-10",
                "value": 45
              },
              {
                "date": "2024-11",
                "value": 40
              },
              {
                "date": "2024-12",
                "value": 35
              },
              {
                "date": "2025-01",
                "value": 30
              },
              {
                "date": "2025-02",
                "value": 28
              },
              {
                "date": "2025-03",
                "value": 30
              },
              {
                "date": "2025-04",
                "value": 35
              },
              {
                "date": "2025-05",
                "value": 40
              },
              {
                "date": "2025-06",
                "value": 38
              },
              {
                "date": "2025-07",
                "value": 35
              },
              {
                "date": "2025-08",
                "value": 32
              }
            ]
          },
          {
            "name": "Target Price (07/18/2024)",
            "unit": "HK$",
            "values": [
              {
                "date": "2024-07-18",
                "value": 62
              }
            ]
          },
          {
            "name": "Target Price (10/22/2024)",
            "unit": "HK$",
            "values": [
              {
                "date": "2024-10-22",
                "value": 40
              }
            ]
          },
          {
            "name": "Target Price (01/21/2025)",
            "unit": "HK$",
            "values": [
              {
                "date": "2025-01-21",
                "value": 26
              }
            ]
          },
          {
            "name": "Target Price (04/01/2025)",
            "unit": "HK$",
            "values": [
              {
                "date": "2025-04-01",
                "value": 26
              }
            ]
          }
        ],
        "figure_id": "ae450930f0fc19e0",
        "provenance": {
          "page": 5
        }
      },
      {
        "type": "other",
        "title": null,
        "page": 1,
        "axes": null,
        "series": [],
        "figure_id": "f221f8258fb46d71",
        "provenance": {
          "page": 1
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 2,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "2024",
              "2025",
              "+12 mo."
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 15,
              "max": 55
            }
          }
        },
        "series": [
          {
            "name": "Historical Data",
            "unit": null,
            "values": [
              45,
              42,
              48,
              43,
              46,
              42,
              37,
              40,
              36,
              38,
              34,
              35,
              32,
              34,
              30,
              27,
              32,
              28,
              30,
              35,
              32,
              38,
              35,
              32,
              36,
              34,
              38,
              35,
              32
            ]
          },
          {
            "name": "Forecast - Upper Bound",
            "unit": null,
            "values": [
              32,
              39
            ]
          },
          {
            "name": "Forecast - Mid Point",
            "unit": null,
            "values": [
              32,
              26
            ]
          },
          {
            "name": "Forecast - Lower Bound",
            "unit": null,
            "values": [
              32,
              18
            ]
          }
        ],
        "figure_id": "a10e3800febcd165",
        "provenance": {
          "page": 2
        }
      }
    ],
    "tables": [],
    "numerical_data": [
      {
        "num_id": "01e0b97676dfdd17",
        "value": -0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "lspan=\"2\">HK$32.50*</td><td></td></tr><tr><td>PRICE TARGET | % TO PT</td><td colspan=\"2\">HK$26.00 | -20%</td><td></td></tr><tr><td>52W HIGH-LOW</td><td colspan=\"2\">HK$48.95 - HK$25.50</td><td></td></t",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "a8b905356f22147f",
        "value": 0.601,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "span=\"2\">HK$48.95 - HK$25.50</td><td></td></tr><tr><td>FLOAT (%) | ADV MM (USD)</td><td colspan=\"2\">60.1% | 58.82</td><td></td></tr><tr><td>MARKET CAP</td><td colspan=\"2\">HK$8.0B | HK$8.0B</td><td></t",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "3ca1bae01a0d511d",
        "value": -0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "O JEFE</td><td>JEF vs CONS</td></tr><tr><td></td><td>2025</td><td>2026</td></tr><tr><td>REV</td><td>-7%</td><td>-9%</td></tr><tr><td>EPS</td><td>+14%</td><td>+20%</td></tr><tr><td></td><td></td><td></",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "7762b0acbfd56886",
        "value": -0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>JEF vs CONS</td></tr><tr><td></td><td>2025</td><td>2026</td></tr><tr><td>REV</td><td>-7%</td><td>-9%</td></tr><tr><td>EPS</td><td>+14%</td><td>+20%</td></tr><tr><td></td><td></td><td></td></tr><tr>",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "e1127675838b5e68",
        "value": 0.14,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>2025</td><td>2026</td></tr><tr><td>REV</td><td>-7%</td><td>-9%</td></tr><tr><td>EPS</td><td>+14%</td><td>+20%</td></tr><tr><td></td><td></td><td></td></tr><tr><td>2025 (RMB)</td><td>1Half</td>",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "75ceb7da6bd919b5",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>2026</td></tr><tr><td>REV</td><td>-7%</td><td>-9%</td></tr><tr><td>EPS</td><td>+14%</td><td>+20%</td></tr><tr><td></td><td></td><td></td></tr><tr><td>2025 (RMB)</td><td>1Half</td><td>2Half</td",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "b111520096bbb93f",
        "value": 26.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "growth, and adjust net profit from the cost saving in SG&A. Maintain UNPF, with PT unchanged at HK\\$26.0. <table><tr><td>FY (Dec)</td><td>2024A</td><td>2025E</td><td>2026E</td><td>2027E</td></tr><tr><",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "edb7a39648e7529e",
        "value": 32.5,
        "unit": "$",
        "metric_type": "currency",
        "context": "td colspan=\"2\">RATING</td><td colspan=\"2\">UNDERPERFORM</td></tr><tr><td>PRICE</td><td colspan=\"2\">HK$32.50*</td><td></td></tr><tr><td>PRICE TARGET | % TO PT</td><td colspan=\"2\">HK$26.00 | -20%</td><td",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "fff6ac919cf9e15d",
        "value": 26.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "td><td colspan=\"2\">HK$32.50*</td><td></td></tr><tr><td>PRICE TARGET | % TO PT</td><td colspan=\"2\">HK$26.00 | -20%</td><td></td></tr><tr><td>52W HIGH-LOW</td><td colspan=\"2\">HK$48.95 - HK$25.50</td><td",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "dd0718a4bfaa92c3",
        "value": 48.95,
        "unit": "$",
        "metric_type": "currency",
        "context": "PT</td><td colspan=\"2\">HK$26.00 | -20%</td><td></td></tr><tr><td>52W HIGH-LOW</td><td colspan=\"2\">HK$48.95 - HK$25.50</td><td></td></tr><tr><td>FLOAT (%) | ADV MM (USD)</td><td colspan=\"2\">60.1% | 58.",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "d6c3162ae01f091b",
        "value": 25.5,
        "unit": "$",
        "metric_type": "currency",
        "context": "colspan=\"2\">HK$26.00 | -20%</td><td></td></tr><tr><td>52W HIGH-LOW</td><td colspan=\"2\">HK$48.95 - HK$25.50</td><td></td></tr><tr><td>FLOAT (%) | ADV MM (USD)</td><td colspan=\"2\">60.1% | 58.82</td><td>",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "13a0130ad7a8703d",
        "value": 8000000000.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "(USD)</td><td colspan=\"2\">60.1% | 58.82</td><td></td></tr><tr><td>MARKET CAP</td><td colspan=\"2\">HK$8.0B | HK$8.0B</td><td></td></tr><tr><td>TICKER</td><td colspan=\"2\">2273 HK</td><td></td></tr><tr><t",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "44647c1252d08089",
        "value": 8000000000.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "><td colspan=\"2\">60.1% | 58.82</td><td></td></tr><tr><td>MARKET CAP</td><td colspan=\"2\">HK$8.0B | HK$8.0B</td><td></td></tr><tr><td>TICKER</td><td colspan=\"2\">2273 HK</td><td></td></tr><tr><td colspan",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "6b97c0c1422e77fd",
        "value": -0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "![Figure 1-0](images/1_0.jpg) <center>Risk/Reward - 12 Month View </center> ## Base Case, HK\\$26,-20% Steady growth in market size of TCM healthcare services. Steady clinic network expansion. Strict",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "24d2afcc99082357",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "linics due to budgeting pressure. PT of HK\\$26 based on DCF valuation. ## Upside Scenario, HK\\$39,+20% Stronger- than- expected growth in TCM healthcare services market size. Faster- than- expected cl",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "2ec10f620aed8c2b",
        "value": -0.45,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "xpected margin expansion. Upside PT of HK\\$39 based on DCF valuation. ## Downside Scenario, HK\\$18,-45% Weaker- than- expected market size growth for TCM healthcare services. Slower- than- expected cl",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "0ff706d92d2859dd",
        "value": 26.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "re. ![Figure 1-0](images/1_0.jpg) <center>Risk/Reward - 12 Month View </center> ## Base Case, HK\\$26,-20% Steady growth in market size of TCM healthcare services. Steady clinic network expansion. S",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "a9b3b754e387f6b5",
        "value": 26.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "twork expansion. Stricter reimbursement policy on TCM clinics due to budgeting pressure. PT of HK\\$26 based on DCF valuation. ## Upside Scenario, HK\\$39,+20% Stronger- than- expected growth in TCM hea",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "b7927ef4a8a81420",
        "value": 39.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "CM clinics due to budgeting pressure. PT of HK\\$26 based on DCF valuation. ## Upside Scenario, HK\\$39,+20% Stronger- than- expected growth in TCM healthcare services market size. Faster- than- expecte",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "bd2bca8e2dfd4d8a",
        "value": 39.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "Faster- than- expected market share gain. Faster- than- expected margin expansion. Upside PT of HK\\$39 based on DCF valuation. ## Downside Scenario, HK\\$18,-45% Weaker- than- expected market size grow",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "ffaa7e3aa21b24e3",
        "value": 18.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "n- expected margin expansion. Upside PT of HK\\$39 based on DCF valuation. ## Downside Scenario, HK\\$18,-45% Weaker- than- expected market size growth for TCM healthcare services. Slower- than- expecte",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "f217840a8d42b70f",
        "value": 18.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "Shrinking market share due to competition. Worse- than- expected margin pressure. Downside PT of HK\\$18 based on DCF valuation. ## Sustainability Matters Top Material Issues: 1) Social responsibility,",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "ca91ef6749e39d00",
        "value": 26.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "isted on the Hong Kong and China stock markets. ## Company Valuation/Risks ## Gushengtang Our HK\\$26.0 price target for Gushengtang is derived from DCF methodology, which factors in our revenue and ea",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "fcd6d75b2bda9aef",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "y price consistently below \\(10, the expected total return (price appreciation plus yield) is minus 20% or less within a 12- month period. NR - The investment rating and price target have been tempora",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "77a92a86f551e353",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "loss. Stocks having 120 day volatility in the bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intended to represent",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "ce1a254ca32cfd8c",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intended to represent a recommended portfolio of stocks and is not ",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "3fcf16c4d47af469",
        "value": 32.5,
        "unit": "$",
        "metric_type": "currency",
        "context": "rowth or value. ## Other Companies Mentioned in This Report Gushengtang Holdings Ltd (2273 HK: HK\\$32.50, UNDERPERFORM) ![Figure 4-0](images/4_0.jpg) <｜end▁of▁sentence｜>",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "388fb3e9ff2514e9",
        "value": 0.606,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>Count</td><td>Percent</td><td>Count</td><td>Percent</td></tr><tr><td>BUY</td><td>2107</td><td>60.60%</td><td>370</td><td>17.56%</td><td>118</td><td>5.60%</td><td></td></tr><tr><td>HOLD</td><td>1",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "037080e9905b5b84",
        "value": 0.17559999999999998,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>Count</td><td>Percent</td></tr><tr><td>BUY</td><td>2107</td><td>60.60%</td><td>370</td><td>17.56%</td><td>118</td><td>5.60%</td><td></td></tr><tr><td>HOLD</td><td>1212</td><td>34.86%</td><td>",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "e59f61ac8a24329f",
        "value": 0.055999999999999994,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ent</td></tr><tr><td>BUY</td><td>2107</td><td>60.60%</td><td>370</td><td>17.56%</td><td>118</td><td>5.60%</td><td></td></tr><tr><td>HOLD</td><td>1212</td><td>34.86%</td><td>107</td><td>8.83%</td><td>2",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "6d58f8b949ee3b69",
        "value": 0.3486,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>370</td><td>17.56%</td><td>118</td><td>5.60%</td><td></td></tr><tr><td>HOLD</td><td>1212</td><td>34.86%</td><td>107</td><td>8.83%</td><td>22</td><td>1.82%</td><td></td></tr><tr><td>UNDERPERFORM</td",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "8aaef7087aea3a18",
        "value": 0.0883,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>118</td><td>5.60%</td><td></td></tr><tr><td>HOLD</td><td>1212</td><td>34.86%</td><td>107</td><td>8.83%</td><td>22</td><td>1.82%</td><td></td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td>",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "87f4f3bcb29ad4bb",
        "value": 0.0182,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td></tr><tr><td>HOLD</td><td>1212</td><td>34.86%</td><td>107</td><td>8.83%</td><td>22</td><td>1.82%</td><td></td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td><td>1.90%</td><",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "685c5d188459e721",
        "value": 0.0454,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "7</td><td>8.83%</td><td>22</td><td>1.82%</td><td></td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td><td>1.90%</td><td>3</td><td>1.90%</td><td></td></tr></table><｜end▁of▁sentence｜>",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "1f2eb274184fdb6d",
        "value": 0.019,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "22</td><td>1.82%</td><td></td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td><td>1.90%</td><td>3</td><td>1.90%</td><td></td></tr></table><｜end▁of▁sentence｜>",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "71f57f639100208c",
        "value": 0.019,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td><td>1.90%</td><td>3</td><td>1.90%</td><td></td></tr></table><｜end▁of▁sentence｜>",
        "provenance": {
          "page": 5
        }
      }
    ],
    "claims": [],
    "relations": [],
    "extraction_summary": {
      "figures_count": 4,
      "tables_count": 0,
      "numerical_data_count": 36,
      "passages_count": 68,
      "entities_count": 20
    }
  }
}